Fund HoldingsCaligan Partners LP

Total Portfolio Value
$315.47M
Total Bought
$28.72M
Total Sold
$173.31M
Net Transaction
-$144.60M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
VERONA PHARMA PLC1,843,7561,436,878-406,87826,66141,33913.10%+14,678
EVOLUS INC2,167,7902,193,488+25,69823,52135,53511.26%+12,014
Y-MABS THERAPEUTICS INC582,0781,195,253+613,1757,03215,7184.98%+8,686
EXELIXIS INC(EXEL)1,525,7301,525,730034,28339,59312.55%+5,310
AGIOS PHARMACEUTICALS INC(AGIO)514,711579,717+65,00622,19425,7578.16%+3,562
MINERALYS THERAPEUTICS INC(MLYS)745,758981,155+235,3978,72511,8823.77%+3,156
ANIKA THERAPEUTICS INC1,435,9931,435,130-86336,37435,44811.24%-926
I MAB3,374,7913,499,330+124,5395,6364,3391.38%-1,297
OUTLOOK THERAPEUTICS INC500,000318,699-181,3013,6901,7020.54%-1,988
BIOCRYST PHARMACEUTICALS INC(BCRX)4,598,7372,583,585-2,015,15228,42019,6356.22%-8,785
ENANTA PHARMACEUTICALS INC1,042,889322,453-720,43613,5263,3411.06%-10,186
LIQUIDIA CORPORATION(LQDA)10,360,9458,118,592-2,242,353124,33181,18625.73%-43,145
ALIMERA SCIENCES INC16,835,1540-16,835,15493,6030-93,603
Page 1 of 1